Amplification and overexpression of androgen receptor gene in hormone-refractory prostate cancer

Cancer Research

Volumn 61, Issue 9, 2001, Pages 3550-3555

  Linja, Marika J ^a   Savinainen, Kimmo J ^a   Saramäki, Outi R ^a   Tammela, Teuvo L J ^b   Vessella, Robert L ^c   Visakorpi, Tapio ^a  

^a UNIVERSITY OF TAMPERE   (Finland)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; RECEPTOR GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR XENOGRAFT;

ANIMALS; GENE AMPLIFICATION; GENE DOSAGE; GENE EXPRESSION; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MICE; NEOPLASMS, HORMONE-DEPENDENT; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 0035328474     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Prospective characterization of pathological features of prostatic carcinomas detected via serum prostate specific antigen based screening
2. Carcinoma of the prostate
3. PSA is an independent prognostic marker in hormonally treated prostate cancer
4. In vivo amplification of the androgen receptor gene and progression of human prostate cancer
5. Androgen receptor gene amplification: A possible molecular mechanism for androgen deprivation therapy failure in prostate cancer
6. Survey of gene amplifications during prostate cancer progression by high-throughput fluorescence in situ hybridization on tissue microarrays
7. Fluorescence in situ hybridization evaluation of c-myc and androgen receptor gene amplification and chromosomal anomalies in prostate cancer in Japanese men
8. Oncogene amplification in tumor cells
9. Genetic basis and clonal evolution of human prostate cancer
10. Increased androgen receptor activity and altered c-myc expression in prostate cancer cells after long-term androgen deprivation
11. Androgen receptor gene amplification at the time of primary progression predicts response to combined androgen blockade as a second-line therapy in advanced prostate cancer
12. The LightCycler: A microvolume multisample fluorimeter with rapid temperature control
13. Quantitation of MYC gene expression in sporadic breast tumors with a real-time reverse transcription-PCR assay
14. Improved technique for analysis of formalin-fixed, paraffin-embedded tumors by fluorescence in situ hybridization
15. New pieces to the prostate cancer puzzle
16. Androgen receptor status in localized and locally progressive hormone refractory human prostate cancer
17. Immunohistochemical study of androgen receptors in metastatic prostate cancer. Comparison of receptor content and response to hormonal therapy
18. Detection of discrete androgen receptor epitopes in prostate cancer by immunostaining: Measurement by color video image analysis
19. Distant metastases from prostatic carcinoma express androgen receptor protein
20. Image analysis of androgen receptor immunostaining in prostate cancer accurately predicts response to hormonal therapy
21. Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer
22. Methylation of the androgen receptor minimal promoter silences transcription in human prostate cancer
23. Quantification of low-copy transcripts by continuous SYBR Green I monitoring during amplification
24. A novel method for real time quantitative RT-PCR
25. Real time quantitative PCR
26. Hormonal regulation of prostate-specific antigen messenger RNA in human prostatic adenocarcinoma cell line LNCaP
27. Decreased concentrations of prostate-specific antigen and human glandular kallikrein 2 in malignant versus nonmalignant prostatic tissue
28. PDEF, a novel prostate epithelium-specific ets transcription factor, interacts with the androgen receptor and activates prostate-specific antigen gene expression
29. A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens
30. Glucocorticoids can promote androgen-independent growth of prostate cancer cells through a mutated androgen receptor
31. Androgen receptor gene mutations in hormone-refractory prostate cancer
32. Undifferentiated carcinoma of the prostate with small cell features: Immunohistochemical subtyping and reflections on histogenesis
33. Characterization of a novel androgen sensitive, prostate specific antigen-producing prostatic carcinoma xenograft: LuCaP 23
34. Selection for androgen receptor mutations in prostate cancers treated with androgen antagonist
35. A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase
36. Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor
37. From HER2/Neu signal cascade to androgen receptor and its coactivators: A novel pathway by induction of androgen target genes through MAP kinase in prostate cancer cells
38. Cloning and characterization of a specific coactivator, ARA70, for the androgen receptor in human prostate cells
39. Promotion of agonist activity of antiandrogens by the androgen receptor coactivator, ARA70, in human prostate cancer DU145 cells
40. Synthesis and evaluation of geldanamycin-testosterone hybrids
41. Inhibition of LncaP prostate cancer cells by means of androgen receptor antisense oligonucleotides